Psychoactive drugs are having a moment. The FDA will soon weigh in
MDMA-assisted therapy can have dramatic positive effects on those suffering from PTSD and other mental illnesses, showcasing its potential as a groundbreaking treatment option. [ more ]
Psychoactive drugs are having a moment. The FDA will soon weigh in
MDMA-assisted therapy can have dramatic positive effects on those suffering from PTSD and other mental illnesses, showcasing its potential as a groundbreaking treatment option. [ more ]
The FDA advisory panel rejected MDMA-assisted therapy for PTSD due to concerns about study designs, participants' ability to guess MDMA use, and potential biases. [ more ]
The FDA advisory panel rejected MDMA-assisted therapy for PTSD due to concerns about study designs, participants' ability to guess MDMA use, and potential biases. [ more ]